Canaccord Defends T2 Biosystems (TTOO), Says Refuting the Short Story, Buy on Weakness

March 5, 2019 1:36 PM

Canaccord analyst Mark Massaro is defending T2 Biosystems (NASDAQ: TTOO) by saying buy on weakness. Analyst comments: "Shares of T2 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found